UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
C C- C1 C3 C5 C6 C7 CA CB CC CD CE CF CG CH CI CJ CK CL CM CN CO CP CQ CR CS CT CU CV CW CX CY CZ
CT- CT5 CTA CTB CTC CTD CTL CTP CTR CTS CTX
selected terms: 198 page 1 of 2

1. CT 1501R
(UMLS (NCI) C0243901) =Organic Chemical; Pharmacologic Substance ;
51. CTX/DM/DNR/VCR
(UMLS (NCI) C0338257) =Therapeutic or Preventive Procedure
2. CT Scan - Cervical & Lumbar
(UMLS (HL7) C1548839) =Health Care Activity =Consent Type;
52. CTX/DM/DOX/MTX
(UMLS (NCI) C0281506) =Therapeutic or Preventive Procedure
3. CT Scan w/ IV Contrast Media into Vein
(UMLS (HL7) C1548840) =Health Care Activity =Consent Type;
53. CTX/DM/DOX/MTX/VCR
(UMLS (NCI) C0280947) =Therapeutic or Preventive Procedure
4. CT-1501R/IL-2
(UMLS (NCI) C0281698) =Therapeutic or Preventive Procedure
54. CTX/DM/DOX/QUIN/VCR/VPAM
(UMLS (NCI) C0280995) =Therapeutic or Preventive Procedure
5. CT-2103
[A protein that can be linked to a chemotherapy drug to deliver the drug directly to the tumor with fewer side effects. It is being studied as a treatment for cancer. ( NCI )] (UMLS (NCI) C0935965) =Organic Chemical; Pharmacologic Substance ;
55. CTX/DM/DOX/VCR/VPAM
(UMLS (NCI) C0279842) =Therapeutic or Preventive Procedure
6. CT-2106
(UMLS (NCI) C1328703) =Organic Chemical; Pharmacologic Substance ;
56. CTX/DM/DOX/VP-16
(UMLS (NCI) C0281664) =Therapeutic or Preventive Procedure ;
7. CT-2584
[A drug that may prevent the growth of blood vessels from surrounding tissue into a solid tumor. It is being studied for its ability to treat cancer. ( NCI )] (UMLS (NCI) C0539091) =Organic Chemical; Pharmacologic Substance ;
57. CTX/DM/G-CSF/VCR
(UMLS (NCI) C0280916) =Therapeutic or Preventive Procedure
8. CT53518
(UMLS (NCI) C1384662) MLN 518;
MLN518;
=Organic Chemical; Pharmacologic Substance
58. CTX/DM/IDA/PEG-ASP/VCR
(UMLS (NCI) C0392952) =Therapeutic or Preventive Procedure
9. CTAD
[Buffered tri-sodium citrate solution with theophylline, adenosine and dipyridamole ( HL7V3.0 )] (UMLS (HL7) C1553428) =Intellectual Product =MaterialEntityAdditive;
59. CTX/DM/MP/MTX/VCR/VP-16
(UMLS (NCI) C0338360) =Therapeutic or Preventive Procedure ;
10. CTAD (this should be spelled out if not universally understood)
(UMLS (HL7) C1550061) =Biomedical or Dental Material; ;
=Additive/Preservative;
60. CTX/DM/VCR
(UMLS (NCI) C0280915) =Therapeutic or Preventive Procedure
11. CTB
[A cytostatic agent that interferes with DNA synthesis. ( NCI )] (UMLS (NCI) C0111753) =Organic Chemical; Pharmacologic Substance ;
61. CTX/DM/VP-16
(UMLS (NCI) C0393044) =Therapeutic or Preventive Procedure
12. CTBP1
[The phosphoprotein C-Terminal Binding Protein 1 (CTBP-1), encoded by the CTBP1 gene, is a transcriptional repressor targeting diverse transcription regulators. CTBP1 binds the C-terminus of adenovirus E1A protein. It also interacts with ELK3 and CTIP via their consensus motif. CTBP1 may play a role during cellular proliferation, adenovirus replication and oncogenic transformation. The level of phosphorylation may be regulated during the cell cycle.CTBP1 can form homodimers or heterodimers of CTBP1 and CTBP2. (From LocusLink, Swiss_Prot) ( NCI )] (UMLS (NCI) C1332650) C-Terminal Binding Protein 1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ◊ [This gene plays a role in the repression of both transcription and cell proliferation. ( NCI )] (UMLS (NCI) C1332799) CTBP1 Gene; C-Terminal Binding Protein 1 Gene Gene or Genome
62. CTX/DNR
(UMLS (NCI) C0338274) =Therapeutic or Preventive Procedure ;
13. CTBP2
[C-Terminal Binding Protein 2, one of the two distinct proteins encoded by the CTBP2 gene, is a transcriptional repressor, while the other isoform is a major component of specialized synapses known as synaptic ribbons. Both proteins contain a NAD+ binding domain similar to NAD+-dependent 2-hydroxyacid dehydrogenases. (from LocusLink) ( NCI )] (UMLS (NCI) C1332651) C-Terminal Binding Protein 2;
Ribeye;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ◊ [This gene is involved in the inhibition of both transcription and cell proliferation. ( NCI )] (UMLS (NCI) C1332800) CTBP2 Gene; C-Terminal Binding Protein 2 Gene Gene or Genome
63. CTX/DNR/MTX/PRED/VCR
(UMLS (NCI) C0280684) =Therapeutic or Preventive Procedure
14. CTCL
[A disease in which certain cells of the lymph system (called T lymphocytes) become cancerous (malignant) and affect the skin. ( NCI )] (UMLS (NCI) C0079773) =Neoplastic Process =Lymphoma, T-Cell;
=MF;
Sezary syndrome;
ALCL;
64. CTX/DNR/PEG-ASP/PRED/VCR
(UMLS (NCI) C0338219) =Therapeutic or Preventive Procedure
15. CTCL Tumor Antigen
[Expressed in brain, placenta, lung, liver, kidney, and pancreas by human EEF1A1 Gene (EF-Tu/EF-1A Family), 462-aa 50-kDa cytoplasmic Elongation Factor 1A1 is the alpha subunit of elongation factor-1 (EEF1) complex and contains domains that bind guanine nucleotides, 80S ribosomes, and aminoacyl-tRNAs. Involved in enzymatic delivery and GTP-dependent binding of aminoacyl-tRNAs to the A-site of 80S ribosomes during protein biosynthesis, EEF1A1 interacts with the beta subunit of EEF1 to hydrolyze GTP to GDP. (NCI) ( NCI )] (UMLS (NCI) C0300140) =Amino Acid, Peptide, or Protein; Biologically Active Substance
65. CTX/DNR/PRED/TG/VCR/VM-26/VP-16
(UMLS (NCI) C0279319) =Therapeutic or Preventive Procedure
16. CTD (Carboxy-Terminal Domain, RNA Polymerase II, Polypeptide A) Small Phosphatase 2 Gene
[This gene plays a role in the transcription and processing of pre-mRNA. ( NCI )] (UMLS (NCI) C1424726) CTDSP2;
CTDSP2 Gene =Gene or Genome
66. CTX/DNR/PRED/VCR
(UMLS (NCI) C0678241) =Therapeutic or Preventive Procedure ;
17. CTL
[antibody-independent "killer cells" derived from the CD8 T lymphocyte line which, when stimulated by antigen, MHC class I antigen, and interleukin 2, secrete cytolytic pore-forming proteins capable of lysing target cells. ( CSP )] (UMLS (NCI) C0039195) =Cell =K cell;
T Cell =Lymphocytes, Tumor-Infiltrating;
67. CTX/DOX/5-FU/FXM/IFN-A/TMX
(UMLS (NCI) C0278515) =Therapeutic or Preventive Procedure
18. CTL A4-Ig B7 Inhibitor
[A human fusion protein with immunosuppressive activity. It consists of the binding domain of human cytotoxic T-lymphocyte-associated antigen 4 and human IgG1. CTLA4-Ig works by binding to CD80 and CD86 on antigen presenting cells, thereby blocking the engagement of CD28 on T-cells, a co-stimulatory signal required for full T-cell activation. This co-stimulatory blocker prevents T-cell activation, and proliferation, and subsequent cytokine production. This T-cell regulatory protein may be useful in treating autoimmune diseases such as rheumatoid arthritis, and may help prevent organ transplant rejection. ( NCI )] (UMLS (NCI) C1172366) CTLA4-Ig;
cytotoxic T lymphocyte-associated antigen-4 =Amino Acid, Peptide, or Protein; Immunologic Factor ;
68. CTX/DOX/5-FU/GM-CSF
(UMLS (NCI) C0279461) =Therapeutic or Preventive Procedure
19. CTL assay
[ ] (UMLS (CSP) C0599717) =Laboratory Procedure ;
69. CTX/DOX/5-FU/GM-CSF/MTX/VCR
(UMLS (NCI) C0279298) =Therapeutic or Preventive Procedure
20. CTLA4
[This gene is involved in T-cell mediation and receptor signal transduction. ( NCI )] (UMLS (NCI) C1332802) CTLA4 Gene;
Cytotoxic T-Lymphocyte-Associated Protein 4 Gene =Gene or Genome
70. CTX/DOX/5-FU/IFN-A
(UMLS (NCI) C0338152) =Therapeutic or Preventive Procedure
21. CTLA8
[Interleukin-17, encoded by the IL17 gene, is a proinflammatory cytokine produced by activated T cells. This cytokine regulates the activities of NF-kappaB and mitogen-activated protein kinases. This cytokine can stimulate the expression of IL6 and cyclooxygenase-2 (PTGS2/COX-2), as well as enhance the production of nitric oxide (NO). High levels of this cytokine are associated with several chronic inflammatory diseases including rheumatoid arthritis, psoriasis and multiple sclerosis. (From LocusLink) ( NCI )] (UMLS (NCI) C0384648) =Amino Acid, Peptide, or Protein; Immunologic Factor ;
71. CTX/DOX/5-FU/MTX
(UMLS (NCI) C0054554) =Therapeutic or Preventive Procedure ;
22. CTLL-2 Assay
[A bioassay used in the detection of interleukin-2 (IL-2) or interleukin-4 (IL-4) in the supernatants of in vitro-stimulated cells. It relies on the IL-2- or IL-4-dependence of a cytotoxic cell line (CTLL-2) for in vitro proliferation, and the measurement of the growth of the these cells is usually determined by tritiated-thymidine incorporation pulsed into the CTLL-2 culture 8-12 hours immediately prior to harvesting the CTLL-2 cells. ( NCI )] (UMLS (NCI) C0201584) =Laboratory Procedure
72. CTX/DOX/5-FU/MTX/PRED
(UMLS (NCI) C0280873) =Therapeutic or Preventive Procedure ;
23. CTP (cytidine triphosphate)
[Cytidine 5'-(tetrahydrogen triphosphate). A cytosine nucleotide containing three phosphate groups esterified to the sugar moiety. ( MSH )] (UMLS (CSP) C0010734) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance ;
73. CTX/DOX/5-FU/MTX/VCR
(UMLS (NCI) C0055984) =Therapeutic or Preventive Procedure
24. CTP-37
[A synthetic peptide vaccine consisting of the carboxy terminal peptide (CTP) of human beta chorionic gonadotropin (beta-hCG). Vaccination with CTP-37 may stimulate the host immune system to produce antibodies against beta-HCG, leading to a decrease in the proliferation of tumor cells that overexpress beta-HCG. (NCI04) ( NCI )] (UMLS (NCI) C0763549) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
74. CTX/DOX/5-FU/SZC
(UMLS (NCI) C0279439) =Therapeutic or Preventive Procedure
25. CTX/5-FU
(UMLS (NCI) C0055160) =Therapeutic or Preventive Procedure
75. CTX/DOX/5-FU/TMX
(UMLS (NCI) C0280682) =Therapeutic or Preventive Procedure
26. CTX/5-FU/FXM/MTX/TMX
(UMLS (NCI) C0280446) =Therapeutic or Preventive Procedure
76. CTX/DOX/5-FU/TMX/ZDX
(UMLS (NCI) C0280706) =Therapeutic or Preventive Procedure
27. CTX/5-FU/LEUP/MTX/TMX
(UMLS (NCI) C0281621) =Therapeutic or Preventive Procedure
77. CTX/DOX/5-FU/VP-16
(UMLS (NCI) C0279442) =Therapeutic or Preventive Procedure
28. CTX/5-FU/MEN
(UMLS (NCI) C0278934) =Therapeutic or Preventive Procedure
78. CTX/DOX/5-FU/ZDX
(UMLS (NCI) C0280707) =Therapeutic or Preventive Procedure
29. CTX/5-FU/MTX/TMX/ZDX
(UMLS (NCI) C0281622) =Therapeutic or Preventive Procedure
79. CTX/DOX/DTIC/VCR
(UMLS (NCI) C0057010) =Therapeutic or Preventive Procedure
30. CTX/5-FU/THP-DOX
(UMLS (NCI) C0338080) =Therapeutic or Preventive Procedure
80. CTX/DOX/G-CSF
(UMLS (NCI) C0280929) =Therapeutic or Preventive Procedure
31. CTX/5-FU/TMX
(UMLS (NCI) C0280462) =Therapeutic or Preventive Procedure
81. CTX/DOX/G-CSF/PRED/VCR
(UMLS (NCI) C0280918) =Therapeutic or Preventive Procedure
32. CTX/5-FU/VCR
(UMLS (NCI) C0056079) =Therapeutic or Preventive Procedure
82. CTX/DOX/G-CSF/PRED/VCR/VP-16
(UMLS (NCI) C0280717) =Therapeutic or Preventive Procedure ;
33. CTX/DACT/DOX/DTIC/VCR
(UMLS (NCI) C0279993) =Therapeutic or Preventive Procedure
83. CTX/DOX/G-CSF/TAX
(UMLS (NCI) C0392996) =Therapeutic or Preventive Procedure
34. CTX/DACT/DOX/G-CSF/VCR
(UMLS (NCI) C0281133) =Therapeutic or Preventive Procedure
84. CTX/DOX/G-CSF/VP-16
(UMLS (NCI) C0280671) =Therapeutic or Preventive Procedure
35. CTX/DACT/DOX/VCR
(UMLS (NCI) C0077966) =Therapeutic or Preventive Procedure ;
85. CTX/DOX/GM-CSF
(UMLS (NCI) C0280667) =Therapeutic or Preventive Procedure
36. CTX/DACT/MTX
(UMLS (NCI) C0065465) =Therapeutic or Preventive Procedure
86. CTX/DOX/GM-CSF/MTX/PAD/VCR/VP-16/ZDV
(UMLS (NCI) C0280768) =Therapeutic or Preventive Procedure
37. CTX/DACT/VBL
(UMLS (NCI) C0280063) =Therapeutic or Preventive Procedure
87. CTX/DOX/GM-CSF/MTX/VCR
(UMLS (NCI) C0279116) =Therapeutic or Preventive Procedure
38. CTX/DACT/VCR
(UMLS (NCI) C0077964) =Therapeutic or Preventive Procedure ;
88. CTX/DOX/GM-CSF/MTX/VCR/VP-16
(UMLS (NCI) C0280767) =Therapeutic or Preventive Procedure
39. CTX/DCF
(UMLS (NCI) C0796444) Cyclophosphamide/Pentostatin =Therapeutic or Preventive Procedure ;
89. CTX/DOX/GM-CSF/PRED/VCR
(UMLS (NCI) C0393011) =Therapeutic or Preventive Procedure
40. CTX/ddI/DOX/VCR/VP-16
(UMLS (NCI) C0281280) =Therapeutic or Preventive Procedure
90. CTX/DOX/GM-CSF/VP-16
(UMLS (NCI) C0279305) =Therapeutic or Preventive Procedure
41. CTX/ddI/DOX/VP-16
(UMLS (NCI) C0281640) =Therapeutic or Preventive Procedure
91. CTX/DOX/IFN-A/IL-2/LAK
(UMLS (NCI) C0278908) =Therapeutic or Preventive Procedure
42. CTX/DES/5-FU
(UMLS (NCI) C0280763) =Therapeutic or Preventive Procedure
92. CTX/DOX/IFN-A/PRED/VCR
(UMLS (NCI) C0338105) =Therapeutic or Preventive Procedure ;
43. CTX/DES/5-FU/MTX
(UMLS (NCI) C0280530) =Therapeutic or Preventive Procedure
93. CTX/DOX/IL-2/VP-16
(UMLS (NCI) C0280109) =Therapeutic or Preventive Procedure
44. CTX/DHAD/L-PAM
(UMLS (NCI) C0392967) =Therapeutic or Preventive Procedure ;
94. CTX/DOX/IL-3/PRED/VCR/ZDV
(UMLS (NCI) C0281253) =Therapeutic or Preventive Procedure ;
45. CTX/DHAD/PEG-ASP/PRED/VCR/VP-16
(UMLS (NCI) C0338349) =Therapeutic or Preventive Procedure ;
95. CTX/DOX/LEUP/TMX
(UMLS (NCI) C0281623) =Therapeutic or Preventive Procedure
46. CTX/DHAD/PRDL/VCR
(UMLS (NCI) C0281609) =Therapeutic or Preventive Procedure ;
96. CTX/DOX/MePRDL/MTX/PRED/VCR
(UMLS (NCI) C0281452) =Therapeutic or Preventive Procedure ;
47. CTX/DHAD/VP-16
(UMLS (NCI) C0338283) =Therapeutic or Preventive Procedure ;
97. CTX/DOX/MePRDL/PRED/VCR
(UMLS (NCI) C0279051) =Therapeutic or Preventive Procedure
48. CTX/DM
(UMLS (NCI) C0281507) =Therapeutic or Preventive Procedure
98. CTX/DOX/MePRDL/VCR
(UMLS (NCI) C0281657) =Therapeutic or Preventive Procedure ;
49. CTX/DM/DNR/MTX/PEG-ASP/VCR
(UMLS (NCI) C0281216) =Therapeutic or Preventive Procedure ;
99. CTX/DOX/MITO
(UMLS (NCI) C0279190) =Therapeutic or Preventive Procedure
50. CTX/DM/DNR/MTX/TSPA/VCR/VP-16
(UMLS (NCI) C0280908) =Therapeutic or Preventive Procedure
100. CTX/DOX/MOAB HER2
(UMLS (NCI) C0338205) =Therapeutic or Preventive Procedure

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.


 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM